Report Highlights
The global market for home medical equipment (HME) is estimated to increase from $43.3 billion in 2022 to $64.8 billion by 2027, at a compound annual growth rate (CAGR) of 8.4% from 2022 through 2027.
Report Includes
- 20 data tables and 32 additional tables
- An up-to-date overview and analysis of the global markets for home medical equipment (HME) within the industry
- Analyses of the global market trends, with historic market revenue (sales data) for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current and future market potential of home medical equipment along with a detailed analysis of competitive environment and trends in market growth
- Evaluation and forecast the actual market size for home medical equipment, and corresponding market share analysis based on product type, disease/condition treated, and geographic region
- Assessment of the major driving factors, opportunities and challenges in this innovation driven market, along with technological developments and regulatory implications within the marketplace
- Updated information on ongoing research activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 effects on this market
- Review of recent patents published and granted on home medical equipment during 2018-2021
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the leading global players, including Abbott, B. Braun Melsungen AG, Baxter International, Becton, Dickinson and Co. (BD), F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., and Medtronic plc
Report Scope
This report is an analytical business tool whose primary purpose is to describe and analyze the dynamics of the global market for home medical equipment. HME is defined as durable equipment—that is, equipment with an expected service life of at least three years that meets the following criteria:
- Can withstand repeated use.
- Is primarily and customarily used to serve a medical purpose.
- Is generally not useful to a person in the absence of an illness or injury.
- Is not implanted inside the patient’s body.
- Is appropriate for use in the home.
- Does not require a trained medical professional to operate.
- Usually requires a doctor’s prescription to buy (excluding most canes, walkers and other elderly and disabled assistive devices).
- Does not generally include drugs and other consumables.
While the report’s coverage is global, it focuses on selected international HME markets including:
- North America.
- Europe.
- Asia-Pacific.
- Rest of the World.
Report Synopsis
| Report Metrics | Details | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||
| Forecast period considered | 2022–2027 | ||||||||||||||
| Base year market size | $40.2 billion | ||||||||||||||
| Market size forecast | $64.8 billion | ||||||||||||||
| Growth rate | CAGR of 8.4 % from 2022 to 2027 | ||||||||||||||
| Units considered | $ Millions | ||||||||||||||
| Segments covered | Product Type, Country/Region, Business Segment, Disease/Condition Treated | ||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Latin America ,Middle East and Africa | ||||||||||||||
| Countries covered | U.S., Canada, Mexico, U.K., Spain, Germany, France, Italy, Australia, South Korea, China, Japan, India, Argentina, Brazil, Saudi Arabia, UAE, South Africa | ||||||||||||||
| Key Market Drivers |
|
||||||||||||||
| Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Technical Textiles: Global Markets (CHM136C)
- Brain-Computer Interface: Global Markets (IAS180B)
- CRISPR Technology: Global Markets (HLC258C)
- Global IoT Testing Services Market (IFT307A)
- Global Markets and Technologies for Nanofiltration (NAN045D)
Report Highlights
The global market for home medical equipment (HME) is expected to grow from $27.8 billion in 2015 to nearly $44.3 billion by 2020, a compound annual growth rate (CAGR) of 9.7% between 2015 and 2020.
Report Includes
- An overview of the global markets for home medical equipment
- Analyses of global market trends, with data from 2014, 2015, and projections of compound annual growth rates (CAGRs) through 2020
- Major product types and applications, both commercial and developmental
- Analyses of the impact of demographic, technological, regulatory and other factors that will drive future demand in different segments
- Market size and segmentation, including historical data on sales by product type and geographical breakdowns
- Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities
- A relevant patent analysis
- Profiles of major players in the home medical equipment industry
Report Highlights
The global market for home medical equipment (HME) was worth $17.9 billion in 2010, nearly $19 billion in 2011, and is expected to reach $26.2 billion by 2016, a CAGR of 6.7%.
Report Highlights
-
The global market for home medical equipment (HME) was worth about $16.8 billion in 2009. BCC expects the HME market to grow to $17.7 billion in 2010 and $23.8 billion by 2015, a CAGR of 6.1% over the next 5 years.
-
The market for therapeutic HME as a group is the fastest growing segment; their share of the total global HME market is expected to increase from about 23% to 28% by 2015. Therapeutic HME was valued at $3.9 billion in 2009 and $4.3 billion in 2010 and will be worth an estimated $6.7 billion by 2015, a compound annual growth rate (CAGR) of 9.3%.
-
Monitors, sensors, and telemetry devices account for the largest share of the HME market, mainly because of the very large market for home blood glucose testers. This segment was worth $7.7 billion in 2009 and $8 billion in 2010. By 2015, this sector will be worth an estimated $11.3 billion, a compound annual growth rate (CAGR) of 7%.
Report Highlights
-
The global home medical equipment market increased from about $13.9 billion in 2006 to an estimated $14.6 billion in 2007. It should reach $20.4 billion by 2012, a compound annual growth rate (CAGR) of 6.8%.
-
The United States and Canada together form the largest geographical market for HME, i.e, 34.2% of the global market.
-
Among the various diseases managed or treated with HME, diabetes accounts for the largest share (i.e., 46.2% in 2006) of the global HME market.
Related Reports
Elder Care Services and Assistive Devices: Global Markets
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Global Market for Pain Management Drugs and Devices
The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.
Global Markets for Telemedicine Technologies
The global market for telemedicine technologies is estimated to increase from $72.4 billion in 2022 to reach $173.3 billion by 2027, with a compound annual growth rate (CAGR) of 19.1% from 2022 through 2027.
Patient Monitoring Devices: Global Markets
The global patient monitoring devices market should reach $42.7 billion by 2022 and more than $65.4 billion by 2027, with a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2022-2027.
Recent Reports
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Global Oncology Pharmaceuticals Market
The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More